fecal microbiota transplantation
GPTKB entity
Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical procedure
|
| gptkbp:alsoKnownAs |
FMT
|
| gptkbp:approvedBy |
FDA (for recurrent C. difficile infection)
|
| gptkbp:category |
gptkb:disease
gastroenterology |
| gptkbp:contraindication |
immunocompromised patients (relative)
|
| gptkbp:cookingMethod |
donor stool processed and filtered
|
| gptkbp:donorScreening |
required to minimize risk of infection
|
| gptkbp:effect |
high cure rate for recurrent C. difficile infection
|
| gptkbp:firstDescribed |
1958
|
| https://www.w3.org/2000/01/rdf-schema#label |
fecal microbiota transplantation
|
| gptkbp:mechanismOfAction |
restoration of healthy gut microbiota
|
| gptkbp:method |
transplantation of fecal bacteria from a healthy donor to a patient
|
| gptkbp:regulates |
regulated as a biologic in the US
|
| gptkbp:relatedTo |
gptkb:antibiotic-associated_diarrhea
microbiome probiotics |
| gptkbp:researchStatus |
ongoing clinical trials for other indications
|
| gptkbp:riskFactor |
gastrointestinal symptoms
transmission of infectious agents |
| gptkbp:routeOfAdministration |
colonoscopy
enema nasogastric tube oral capsules |
| gptkbp:usedFor |
investigational treatment for irritable bowel syndrome
investigational treatment for inflammatory bowel disease treatment of recurrent Clostridioides difficile infection |
| gptkbp:bfsParent |
gptkb:Clostridioides_difficile_infection
|
| gptkbp:bfsLayer |
5
|